Crohn's Disease and Colitis Trial, Recruiting NCT06241170 Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06241170
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been clearly diagnosed with Crohn's disease (CD) and your doctor has determined you need surgery to remove the area where your small intestine meets your large intestine (called the ileocecal region), done in a single operation
  • Your Crohn's disease affects only the end of the small intestine and the start of the large intestine, with the total affected area being less than 80 cm in length
  • The area of intestine just above where the surgical join will be made (within about 50 cm) shows no signs of remaining disease
  • You (or your legal guardian) are able to understand the study, are willing to take part, can sign a consent form, and are able to follow the study plan

Who may not be able to join:

  • You have previously had surgery to remove the ileocecal region of your intestine
  • Your Crohn's disease mainly affects other parts of the intestine (such as higher up in the small bowel) and requires surgical removal of areas other than the ileocecal region
  • There is a risk that removing intestine could leave you with too little intestine to absorb nutrients properly (sometimes called short bowel syndrome)
  • You would need a temporary or permanent opening of the intestine through the abdominal wall (an ileostomy) as part of your surgery
  • You have severe disease affecting the area around your back passage (anus and rectum)
  • It is expected that you would not be able to take the required medications after surgery
  • You are unable to return to the hospital for follow-up check-ups at the required times
  • You have had a serious heart or other major health problem in the six months before surgery, such as a heart attack, active chest pain (angina), heart failure, or another condition the study doctor feels puts you at risk
  • You have a history of cancer, including melanoma (a type of skin cancer), not including certain minor localised skin cancers
  • You have been diagnosed with another autoimmune disease (a condition where the immune system attacks the body) in addition to Crohn's disease, or there is evidence suggesting you may have one
  • You are currently pregnant or breastfeeding
  • You are not able to be contacted or assessed at the required points throughout the study

You may be removed from the trial if:

  • You cannot be reached for follow-up or you choose to leave the study
  • A complication develops at the surgical join site (anastomotic fistula) that makes it impossible to carry out the required camera examinations (confirm with trial site)
  • The study doctor decides it is no longer appropriate for you to continue

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The Modified Rutgeerts Score during colonoscopy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov